CJC-1295 no DAC meaning explained: what the no-DAC label signals, how this GHRH analog differs from the DAC version, and what research shows.
CJC-1295 no DAC meaning is simple: it describes CJC-1295 without the Drug Affinity Complex, the chemical linker that tethers the peptide to albumin in the bloodstream. Remove that linker and you are left with modified GRF(1-29), a short-acting GHRH analog whose half-life is measured in minutes rather than days. In practice, the label tells you the product is designed for faster, pulsatile signaling rather than steady, long-lasting exposure.
What "No DAC" Actually Means
DAC stands for Drug Affinity Complex. In CJC-1295 with DAC, a maleimidopropionic acid linker attaches the peptide to albumin, a blood protein that acts as a natural slow-release carrier. That single modification is what stretches the compound's half-life from roughly 30 minutes to about a week.
The no-DAC form keeps the four amino acid substitutions that resist enzymatic breakdown but drops the linker entirely. That is why it is also sold and studied under names like Mod GRF(1-29), modified GRF 1-29, and tetra-substituted GRF(1-29).
- CJC-1295 with DAC: albumin-bound, long-acting, and usually researched with infrequent administration.
- CJC-1295 no DAC: unbound, short-acting, and usually researched with smaller, more frequent administration.
CJC-1295 DAC vs No DAC: Side-by-Side
| Feature | CJC-1295 with DAC | CJC-1295 no DAC (Mod GRF 1-29) |
|---|---|---|
| Albumin binding | Yes, through the DAC linker | No |
| Approximate half-life | About 6 to 8 days | About 30 minutes |
| Typical research schedule | Weekly or every few days | Multiple times per day |
| Alternative names | CJC-1295, DAC:GRF | Mod GRF(1-29), tetra-substituted GRF(1-29) |
| FDA approval for human use | Not approved | Not approved |
The cjc-1295 dac vs no dac comparison usually comes down to half-life and control. A long-acting version produces a steady signal, while the no-DAC version produces sharp spikes that fade quickly. Neither is inherently better on paper; they simply mimic different release patterns.
Why the Shorter Half-Life Gets Attention
Natural growth hormone release is pulsatile, with the largest surges occurring during deep sleep and after intense exercise. A compound that clears in about 30 minutes fits that pattern more closely than one that lingers for a week.
Researchers who choose the no-DAC version usually point to three practical reasons:
- Clearance is fast enough that administration can be timed around natural pulses.
- Exposure can be adjusted day to day instead of waiting out a long half-life.
- It pairs predictably with shorter-acting ghrelin receptor agonists.
Those are pharmacokinetic arguments, not proof of benefit. No large human trial has compared the two forms head to head for body composition, recovery, or any other outcome.
Half-Life, Dosage, and What the Numbers Mean
Search interest in cjc-1295 no dac dosage is high, but there is no published human dosing schedule for this compound. Nearly every number circulating online traces back to vendor labels or user logs rather than controlled clinical trials.
The cjc 1295 no dac half-life of roughly 30 minutes explains why users report injecting several times a day, often before meals or before sleep. That schedule reflects how fast the peptide clears; it does not establish a safe or effective dose.
Vials typically arrive as lyophilized powder that must be reconstituted with bacteriostatic water, refrigerated, and used within a set window. Purity, sterility, and actual peptide content vary widely between suppliers, and independent lab testing is uncommon.
Stacks, Blends, and Online Anecdotes
CJC-1295 no DAC is most often paired with ipamorelin, a selective ghrelin receptor agonist. The theory is that one compound supports GHRH signaling while the other amplifies the growth hormone pulse.
Vendors sell combination vials with a suggested cjc-1295 no dac ipamorelin 10mg blend dosage printed on the label, but those figures come from marketing copy rather than research. Forum posts describing personal results, side effects, and bloodwork are common, and they remain anecdotes rather than evidence.
Safety and Legal Status in the United States
CJC-1295 no DAC is not FDA-approved for human use. It is sold as a research chemical, which means it is not subject to the purity, potency, and labeling standards required of prescription drugs.
Reported effects of GHRH analogs in research settings include injection site reactions, fluid retention, joint discomfort, and changes in blood glucose. Long-term safety data for the no-DAC version in humans is essentially absent.
People also ask about tesamorelin vs cjc-1295 no dac. Tesamorelin is an FDA-approved GHRH analog for a specific diagnosed condition, while CJC-1295 no DAC has no approved medical indication at all.
Anyone weighing these compounds should talk with a licensed healthcare professional first, especially when taking medication for diabetes, thyroid disease, or any hormone-sensitive condition.
Bottom Line
CJC-1295 no DAC means the peptide is missing the albumin-binding linker that makes standard CJC-1295 long-acting. The result is a roughly 30-minute half-life, frequent administration in practice, and research-only status in the United States. The label describes chemistry and pharmacokinetics, not approved medical use.
Frequently Asked Questions
What does "no DAC" mean in CJC-1295?
DAC stands for Drug Affinity Complex, a linker that binds CJC-1295 to albumin in the blood and extends its half-life to about 6 to 8 days. CJC-1295 no DAC removes that linker, leaving modified GRF(1-29), which clears in roughly 30 minutes.
Is CJC-1295 no DAC legal or FDA-approved in the US?
No. CJC-1295 no DAC is not FDA-approved for human use and is generally sold as a research chemical rather than a prescription drug. That means it has not been reviewed by regulators for safety, purity, or effectiveness in people.
How long does CJC-1295 no DAC stay in your system?
Its half-life is roughly 30 minutes, so most of the peptide is cleared within a few hours of administration. The DAC version lasts far longer because albumin binding keeps it circulating for about a week.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.